medigraphic.com
Órgano Oficial de la Asociación Mexicana de Hepatología

2018, Número 3

<< Anterior Siguiente >>

Ann Hepatol 2018; 17 (3)


Vitamin D Deficiency is not Associated with Fatty Liver in a Mexican Population

López-Bautista F, Posadas-Romero C, Ruiz-Vargas LY, Cardoso-Saldaña G, Juárez-Rojas JG, Medina-Urrutia A, Pérez-Hernández N, Rodríguez-Pérez JM, Vargas-Alarcón G, Posadas-Sánchez R

Idioma: Ingles.
Referencias bibliográficas: 50
Paginas: 419-425
Archivo PDF: 195.61 Kb.


RESUMEN

Sin resumen.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Holick MF. Vitamin D deficiency. N Engl J Med 2007; 357: 266-81.

  2. Verstuyf A, Carmeliet G, Bouillon R, Mathieu C. Vitamin D: a pleiotropic hormone. Kidney Int 2010; 78: 140-5.

  3. Holick MF, Biancuzzo RM, Chen TC, Klein EK, Young A, Bibuld D, Reitz R, et al. Vitamin D2 is as effective as vitamin D3 in maintaining circulating concentrations of 25-hydroxyvitamin D. J Clin Endocrinol Metab 2008; 93: 677-81.

  4. Calatayud M, Jódar E, Sánchez R, Guadalix S, Hawkins F. Prevalencia de concentraciones deficientes e insuficientes de vitamina D en una población joven y sana. Endocrinol y Nutr 2009; 56: 164-9.

  5. Flores M, Sánchez-Romero LM, Macias N, Lozada A, Díaz E, Barquera S. Concentraciones séricas de vitamina D en niños, adolescentes y adultos mexicanos. Resultados de la ENSANUT 2006. Cuernavaca, México: Instituto Nacional de Salud Pública; 2011.

  6. Chacko SA, Song Y, Manson JE, Horn L Van, Eaton C, Martin LW, McTiernan A, et al. Serum 25-hydroxyvitamin D concentrations in relation to cardiometabolic risk factors and metabolic syndrome in postmenopausal women. Am J Clin Nutr 2011; 94: 209-17.

  7. Martins D, Wolf M, Pan D, Zadshir A, Tareen N, Thadhani R, Felsenfeld A, et al. Prevalence of cardiovascular risk factors and the serum levels of 25-hydroxyvitamin D in the United States: data from the Third National Health and Nutrition Examination Survey. Arch Intern Med 2007; 167: 1159-65.

  8. Kim MK, Il Kang M, Won Oh K, Kwon HS, Lee JH, Lee WC, Yoon K-H, et al. The association of serum vitamin D level with presence of metabolic syndrome and hypertension in middle-aged Korean subjects. Clin Endocrinol (Oxf) 2010; 73: 330-8.

  9. Lazo M, Clark JM. The epidemiology of nonalcoholic fatty liver disease: a global perspective. Semin Liver Dis 2008; 28: 339-50.

  10. Satapathy SK, Sanyal AJ. Epidemiology and Natural History of Nonalcoholic Fatty Liver Disease. Semin Liver Dis 2015; 35: 221-35.

  11. Martínez-Alvarado MDR, Juárez-Rojas JG, Medina-Urrutia AX, Cardoso-Saldaña GC, González-Salazar MDC, Posadas- Sánchez R, Jorge-Galarza E, et al. Association of fatty liver with cardiovascular risk factors and subclinical atherosclerosis in a Mexican population. Rev Invest Clin 2014; 66: 407- 14.

  12. Bril F, Maximos M, Portillo-Sanchez P, Biernacki D, Lomonaco R, Subbarayan S, Correa M, et al. Relationship of vitamin D with insulin resistance and disease severity in non-alcoholic steatohepatitis. J Hepatol 2015; 62: 405-11.

  13. Hourigan SK, Abrams S, Yates K, Pfeifer K, Torbenson M, Murray K, Roth CL, et al. Relation between vitamin D status and nonalcoholic fatty liver disease in children. J Pediatr Gastroenterol Nutr 2015; 60: 396-404.

  14. Barchetta I, Angelico F, Del Ben M, Baroni MG, Pozzilli P, Morini S, Cavallo MG. Strong association between non alcoholic fatty liver disease (NAFLD) and low 25(OH) vitamin D levels in an adult population with normal serum liver enzymes. BMC Med 2011; 9: 85.

  15. Zhai HL, Wang NJ, Han B, Li Q, Chen YC, Zhu CF, Chen YC, et al. Low vitamin D levels and non-alcoholic fatty liver disease, evidence for their independent association in men in East China: a cross-sectional study (Survey on Prevalence in East China for Metabolic Diseases and Risk Factors (SPECT-China)). Br J Nutr 2016; 115: 1352-9.

  16. Seo JA, Eun CR, Cho H, Lee SK, Yoo HJ, Kim SG, Choi KM, et al. Low vitamin D status is associated with nonalcoholic Fatty liver disease independent of visceral obesity in Korean adults. PLoS One 2013; 8: e75197.

  17. Holick MF. Vitamin D deficiency. N Engl J Med 2007; 357: 266-81.

  18. Verstuyf A, Carmeliet G, Bouillon R, Mathieu C. Vitamin D: a pleiotropic hormone. Kidney Int 2010; 78: 140-5.

  19. Holick MF, Biancuzzo RM, Chen TC, Klein EK, Young A, Bibuld D, Reitz R, et al. Vitamin D2 is as effective as vitamin D3 in maintaining circulating concentrations of 25-hydroxyvitamin D. J Clin Endocrinol Metab 2008; 93: 677-81.

  20. Calatayud M, Jódar E, Sánchez R, Guadalix S, Hawkins F. Prevalencia de concentraciones deficientes e insuficientes de vitamina D en una población joven y sana. Endocrinol y Nutr 2009; 56: 164-9.

  21. Flores M, Sánchez-Romero LM, Macias N, Lozada A, Díaz E, Barquera S. Concentraciones séricas de vitamina D en niños, adolescentes y adultos mexicanos. Resultados de la ENSANUT 2006. Cuernavaca, México: Instituto Nacional de Salud Pública; 2011.

  22. Chacko SA, Song Y, Manson JE, Horn L Van, Eaton C, Martin LW, McTiernan A, et al. Serum 25-hydroxyvitamin D concentrations in relation to cardiometabolic risk factors and metabolic syndrome in postmenopausal women. Am J Clin Nutr 2011; 94: 209-17.

  23. Martins D, Wolf M, Pan D, Zadshir A, Tareen N, Thadhani R, Felsenfeld A, et al. Prevalence of cardiovascular risk factors and the serum levels of 25-hydroxyvitamin D in the United States: data from the Third National Health and Nutrition Examination Survey. Arch Intern Med 2007; 167: 1159-65.

  24. Kim MK, Il Kang M, Won Oh K, Kwon HS, Lee JH, Lee WC, Yoon K-H, et al. The association of serum vitamin D level with presence of metabolic syndrome and hypertension in middle-aged Korean subjects. Clin Endocrinol (Oxf) 2010; 73: 330-8.

  25. Lazo M, Clark JM. The epidemiology of nonalcoholic fatty liver disease: a global perspective. Semin Liver Dis 2008; 28: 339-50.

  26. Satapathy SK, Sanyal AJ. Epidemiology and Natural History of Nonalcoholic Fatty Liver Disease. Semin Liver Dis 2015; 35: 221-35.

  27. Martínez-Alvarado MDR, Juárez-Rojas JG, Medina-Urrutia AX, Cardoso-Saldaña GC, González-Salazar MDC, Posadas- Sánchez R, Jorge-Galarza E, et al. Association of fatty liver with cardiovascular risk factors and subclinical atherosclerosis in a Mexican population. Rev Invest Clin 2014; 66: 407- 14.

  28. Bril F, Maximos M, Portillo-Sanchez P, Biernacki D, Lomonaco R, Subbarayan S, Correa M, et al. Relationship of vitamin D with insulin resistance and disease severity in non-alcoholic steatohepatitis. J Hepatol 2015; 62: 405-11.

  29. Hourigan SK, Abrams S, Yates K, Pfeifer K, Torbenson M, Murray K, Roth CL, et al. Relation between vitamin D status and nonalcoholic fatty liver disease in children. J Pediatr Gastroenterol Nutr 2015; 60: 396-404.

  30. Barchetta I, Angelico F, Del Ben M, Baroni MG, Pozzilli P, Morini S, Cavallo MG. Strong association between non alcoholic fatty liver disease (NAFLD) and low 25(OH) vitamin D levels in an adult population with normal serum liver enzymes. BMC Med 2011; 9: 85.

  31. Zhai HL, Wang NJ, Han B, Li Q, Chen YC, Zhu CF, Chen YC, et al. Low vitamin D levels and non-alcoholic fatty liver disease, evidence for their independent association in men in East China: a cross-sectional study (Survey on Prevalence in East China for Metabolic Diseases and Risk Factors (SPECT-China)). Br J Nutr 2016; 115: 1352-9.

  32. Seo JA, Eun CR, Cho H, Lee SK, Yoo HJ, Kim SG, Choi KM, et al. Low vitamin D status is associated with nonalcoholic Fatty liver disease independent of visceral obesity in Korean adults. PLoS One 2013; 8: e75197.

  33. Posadas-Romero C, Jorge-Galarza E, Posadas-Sánchez R, , , Acuña-Valerio J, Juárez-Rojas JG, Kimura-Hayama E, Medina- Urrutia A, et al. Fatty liver largely explains associations of subclinical hypothyroidism with insulin resistance, metabolic syndrome, and subclinical coronary atherosclerosis. Eur J Endocrinol 2014; 171: 319-25.

  34. Hernández-Avila M, Romieu I, Parra S, Hernández-Avila J, Madrigal H, Willett W. Validity and reproducibility of a food frequency questionnaire to assess dietary intake of women living in Mexico City. Salud Publica Mex 1998; 40: 133-40.

  35. Baecke JAH, Burema J, Frijters JER. A short questionnaire for the measurement of habitual physical activity in epidemiological studies. Am J Clin Nutr 1982; 36: 936-42.

  36. DeLong DM, DeLong ER, Wood PD, Lippel K, Rifkind BM. A comparison of methods for the estimation of plasma lowand very low-density lipoprotein cholesterol. The Lipid Research Clinics Prevalence Study. JAMA 1986; 256: 2372-7.

  37. Wallace TM, Levy JC, Matthews DR. Use and abuse of HOMA modeling. Diabetes Care 2004; 27: 1487-95.

  38. American Diabetes Association. Standards of medical care in diabetes--2009. Diabetes Care 2009; 32(Suppl. 1): S13- 61.

  39. Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, Murad MH, et al. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2011; 96: 1911-30.

  40. Hernández-Ávila M, Resoles M, Parra S, Romieu I. Sistema de evaluación de hábitos nutricionales y consumo de nutrimentos (SNUT). México: INSP.

  41. Kvist H, Chowdhury B, Grangård U, Tylén U, Sjöström L. Total and visceral adipose-tissue volumes derived from measurements with computed tomography in adult men and women: predictive equations. Am J Clin Nutr 1988; 48: 1351-61.

  42. Longo R, Ricci C, Masutti F, Vidimari R, Crocé LS, Bercich L, Tiribelli C, et al. Fatty infiltration of the liver. Quantification by 1H localized magnetic resonance spectroscopy and comparison with computed tomography. Invest Radiol 1993; 28: 297-302.

  43. McKimmie RL, Daniel KR, Carr JJ, Bowden DW, Freedman BI, Register TC, Hsu F-C, et al. Hepatic steatosis and subclinical cardiovascular disease in a cohort enriched for type 2 diabetes: The Diabetes Heart Study. Am J Gastroenterol 2008; 103: 3029-35.

  44. Catena C, Cosma C, Camozzi V, Plebani M, Ermani M, Sechi LA, Fallo F. Non-alcoholic fatty liver disease is not associated with vitamin D deficiency in essential hypertension. High Blood Press Cardiovasc Prev 2013; 20: 33-7.

  45. Sezer OB, Bulus D, Hιzlι S, Andιran N, Yιlmaz D, Ramadan SU. Low 25-hydroxyvitamin D level is not an independent risk factor for hepatosteatosis in obese children. J Pediatr Endocrinol Metab 2016; 29: 783-8.

  46. Katz K, Brar PC, Parekh N, Liu Y-H, Weitzman M. Suspected nonalcoholic Fatty liver disease is not associated with vitamin D status in adolescents after adjustment for obesity. J Obes 2010; 2010: 496829.

  47. Patel YA, Henao R, Moylan CA, Guy CD, Piercy DL, Mae Diehl A, Abdelmalek MF. Vitamin D is not associated with Severity in NAFLD: Results of a Paired Clinical and Gene Expression Profile Analysis. Nat Publ Gr 2016; 111: 1591-8.

  48. Limanond P, Raman SS, Lassman C, Sayre J, Ghobrial RM, Busuttil RW, Saab S, et al. Macrovesicular hepatic steatosis in living related liver donors: correlation between CT and histologic findings. Radiology 2004; 230: 276-80.

  49. Pearce SHS, Cheetham TD. Diagnosis and management of vitamin D deficiency. Br Med J 2010; 340: 142-47.

  50. Kasahara AK, Singh RJ, Noymer A. Vitamin D (25OHD) serum seasonality in the United States. PLoS One 2013; 8: e65785.




2020     |     www.medigraphic.com